Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136)

C. C. Chang, M. H. Yang, B. R. Lin, S. T. Chen, S. H. Pan, M. Hsiao, T. C. Lai, S. K. Lin, Y. M. Jeng, C. Y. Chu, R. H. Chen, P. C. Yang, Y. Eugene Chin*, M. L. Kuo

*此作品的通信作者

研究成果: Comment/debate

2 引文 斯高帕斯(Scopus)

摘要

Following publication of their article “CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation”, the authors reported an error in Fig.6b. α-Tubulin image of rCCN2 treatment (upper panel in CL1-5) only showed eight lanes, when there should be nine.

原文English
頁(從 - 到)196
頁數1
期刊Cell Death and Differentiation
26
發行號1
DOIs
出版狀態Published - 1 1月 2019

指紋

深入研究「Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136)」主題。共同形成了獨特的指紋。

引用此